{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:21:44Z","timestamp":1789809704537,"version":"4.0.1"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"1102","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:p>Nasopharyngeal carcinoma (NPC) is a malignancy with unique clinical biological profiles such as associated Epstein-Barr virus infection and high radiosensitivity. Radiotherapy has long been recognized as the mainstay for the treatment of NPC. However, the further efficacy brought by radical radiotherapy has reached the bottleneck in advanced patients, who are prone to develop recurrence and distant metastasis after treatment. The application of photon therapy makes it possible for radiation dose escalation in refractory cases and may provide second chance for recurrent patients with less unrecoverable tissue damage. The concept of adaptive radiotherapy is put forward in consideration of target volume shrinkage during treatment. The replanning procedure offers better protection for the organ at risk. However, the best timing and candidates for adaptive radiotherapy is still under debate. The current tendency of artificial intelligence in NPC mainly focuses on image recognition, auto-segmentation and dose prediction. Although artificial intelligence is still in developmental stage, the future of it is promising.<\/jats:p>\n               <jats:p>To further improve the efficacy of NPC, multimodality treatment is encouraged. In-depth studies on genetic and epigenetic variations help to explain the great heterogeneity among patients, and could further be applied to precise screening and prediction, personalized radiotherapy and the evolution of targeted drugs. Given the clinical benefit of immunotherapy in other cancers, the application of immunotherapy, especially immune checkpoint inhibitor, in NPC is also of great potential. Results from ongoing clinical trials combining immunotherapy with radiotherapy in NPC are expected.<\/jats:p>","DOI":"10.1259\/bjr.20190209","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T16:58:07Z","timestamp":1562086687000},"source":"Crossref","is-referenced-by-count":97,"title":["Future of Radiotherapy in Nasopharyngeal Carcinoma"],"prefix":"10.1093","volume":"92","author":[{"given":"Xue-Song","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East , Guangzhou , P R China"},{"name":"Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East , Guangzhou , P R China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East , Guangzhou , P R China"},{"name":"Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East , Guangzhou , P R China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East , Guangzhou , P R China"},{"name":"Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East , Guangzhou , P R China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Quan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East , Guangzhou , P R China"},{"name":"Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East , Guangzhou , P R China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qiang","family":"Mai","sequence":"additional","affiliation":[{"name":"Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East , Guangzhou , P R China"},{"name":"Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, 651 Dongfeng Road East , Guangzhou , P R China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"key":"2024050214502308900_b1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma","volume":"365","author":"Wei","year":"2005","journal-title":"Lancet"},{"key":"2024050214502308900_b2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiother Oncol"},{"key":"2024050214502308900_b3","first-page":"415","article-title":"Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. International journal of radiation oncology, biology","volume":"85","author":"Tsai","year":"2013","journal-title":"Physics"},{"key":"2024050214502308900_b4","first-page":"23","article-title":"Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. International journal of radiation oncology, biology","volume":"53","author":"Eisbruch","year":"2002","journal-title":"Physics"},{"key":"2024050214502308900_b5","first-page":"1440","article-title":"Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. International journal of radiation oncology, biology","volume":"60","author":"Kam","year":"2004","journal-title":"Physics"},{"key":"2024050214502308900_b6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0360-3016(02)02724-4","article-title":"Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience","volume":"53","author":"Lee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050214502308900_b7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.meddos.2007.02.006","article-title":"Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord","volume":"32","author":"Chau","year":"2007","journal-title":"Med Dosim"},{"key":"2024050214502308900_b8","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1002\/cncr.25773","article-title":"Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with &gt;5 years of follow-up","volume":"117","author":"Chen","year":"2011","journal-title":"Cancer"},{"key":"2024050214502308900_b9","first-page":"943","article-title":"Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance? International journal of radiation oncology, biology","volume":"81","author":"Chen","year":"2011","journal-title":"Physics"},{"key":"2024050214502308900_b10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.ijrobp.2004.05.022","article-title":"Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience","volume":"60","author":"Kam","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050214502308900_b11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","article-title":"How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?","volume":"80","author":"Lai","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050214502308900_b12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"2024050214502308900_b13","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.ejca.2015.08.006","article-title":"Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up","volume":"51","author":"Zhang","year":"2015","journal-title":"Eur J Cancer"},{"key":"2024050214502308900_b14","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","article-title":"Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy","volume":"26","author":"Langendijk","year":"2008","journal-title":"J Clin Oncol"},{"key":"2024050214502308900_b15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0167-8140(96)91805-8","article-title":"Chordoma: long-term follow-up after radical photon irradiation","volume":"41","author":"Catton","year":"1996","journal-title":"Radiother Oncol"},{"key":"2024050214502308900_b16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0161-6420(80)35212-3","article-title":"Proton beam irradiation. An alternative to enucleation for intraocular melanomas","volume":"87","author":"Gragoudas","year":"1980","journal-title":"Ophthalmology"},{"key":"2024050214502308900_b17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1748-717X-3-4","article-title":"Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons","volume":"3","author":"Taheri-Kadkhoda","year":"2008","journal-title":"Radiat Oncol"},{"key":"2024050214502308900_b18","first-page":"589","article-title":"Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. International journal of radiation oncology, biology","volume":"72","author":"Widesott","year":"2008","journal-title":"Physics"},{"issue":"Suppl 1","key":"2024050214502308900_b19","first-page":"E1886","article-title":"Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes","volume":"38 Suppl 1","author":"Lewis","year":"2016","journal-title":"Head Neck"},{"key":"2024050214502308900_b20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0167-8140(01)00403-0","article-title":"A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours","volume":"61","author":"Cozzi","year":"2001","journal-title":"Radiother Oncol"},{"key":"2024050214502308900_b21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.radonc.2006.07.025","article-title":"Intensity modulated photon and proton therapy for the treatment of head and neck tumors","volume":"80","author":"Steneker","year":"2006","journal-title":"Radiother Oncol"},{"key":"2024050214502308900_b22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/hed.20737","article-title":"Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy","volume":"30","author":"Capuano","year":"2008","journal-title":"Head Neck"},{"key":"2024050214502308900_b23","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2004.22.90140.5574","article-title":"Proton radiotherapy for T4 nasopharyngeal carcinoma Journal of clinical oncology","author":"Chan AW","year":"2004","journal-title":"official journal of the American Society of Clinical Oncology"},{"key":"2024050214502308900_b24","first-page":"S151","article-title":"A phase II trial of proton radiation therapy with chemotherapy for nasopharyngeal carcinoma International journal of radiation oncology, biology","volume":"84","author":"Chan","year":"2012","journal-title":"Physics"},{"key":"2024050214502308900_b25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.prro.2011.02.001","article-title":"Implications of comparative effectiveness research for radiation oncology","volume":"1","author":"Bekelman","year":"2011","journal-title":"Pract Radiat Oncol"},{"key":"2024050214502308900_b26","first-page":"e47","article-title":"Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. International journal of radiation oncology, biology","volume":"85","author":"Yang","year":"2013","journal-title":"Physics"},{"key":"2024050214502308900_b27","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/hed.23477","article-title":"Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning","volume":"36","author":"Chen","year":"2014","journal-title":"Head Neck"},{"key":"2024050214502308900_b28","first-page":"1360","article-title":"Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. International journal of radiation oncology, biology","volume":"76","author":"Bhide","year":"2010","journal-title":"Physics"},{"key":"2024050214502308900_b29","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/lary.20601","article-title":"Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study","volume":"119","author":"Wang","year":"2009","journal-title":"Laryngoscope"},{"key":"2024050214502308900_b30","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130363","article-title":"Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy","volume":"86","author":"Sanguineti","year":"2013","journal-title":"Br J Radiol"},{"key":"2024050214502308900_b31","first-page":"676","article-title":"Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer. International journal of radiation oncology, biology","volume":"87","author":"Hunter","year":"2013","journal-title":"Physics"},{"key":"2024050214502308900_b32","first-page":"677","article-title":"Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications. International journal of radiation oncology, biology","volume":"80","author":"Ahn","year":"2011","journal-title":"Physics"},{"key":"2024050214502308900_b33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2012.10.010","article-title":"Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial","volume":"106","author":"Schwartz","year":"2013","journal-title":"Radiother Oncol"},{"key":"2024050214502308900_b34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/ajco.12516","article-title":"Head and neck adaptive radiotherapy: Predicting the time to replan","volume":"12","author":"Brown","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"2024050214502308900_b35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2015.05.018","article-title":"Identifying patients who may benefit from adaptive radiotherapy: Does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help?","volume":"115","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"2024050214502308900_b36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"issue":"3 Suppl","key":"2024050214502308900_b37","first-page":"S58","article-title":"Radiotherapy dose-volume effects on salivary gland function. International journal of radiation oncology, biology","volume":"76","author":"Deasy","year":"2010","journal-title":"Physics"},{"key":"2024050214502308900_b38","first-page":"1132","article-title":"Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma","volume":"28","author":"Yu","year":"2009","journal-title":"Ai Zheng"},{"key":"2024050214502308900_b39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2013.07.016","article-title":"The effect of induction chemotherapy on tumor volume and organ-at-risk doses in patients with locally advanced oropharyngeal cancer","volume":"109","author":"Doornaert","year":"2013","journal-title":"Radiother Oncol"},{"key":"2024050214502308900_b40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","year":"2017","journal-title":"Nature"},{"key":"2024050214502308900_b41","doi-asserted-by":"crossref","first-page":"canres.0494.2018","DOI":"10.1158\/0008-5472.CAN-18-0494","article-title":"Identification of Metastatic Lymph Nodes in MR Imaging with Faster Region-based Convolutional Neural Network","volume":"78","author":"Lu","year":"2018","journal-title":"Cancer Res"},{"key":"2024050214502308900_b42","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1148\/radiol.2262011843","article-title":"Breast lesions on sonograms: computer-aided diagnosis with nearly setting-independent features and artificial neural networks","volume":"226","author":"Chen","year":"2003","journal-title":"Radiology"},{"key":"2024050214502308900_b43","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1158\/0008-5472.CAN-18-0696","article-title":"3D Deep Learning from CT Scans Predicts Tumor Invasiveness of Subcentimeter Pulmonary Adenocarcinomas","volume":"78","author":"Zhao","year":"2018","journal-title":"Cancer Res"},{"key":"2024050214502308900_b44","doi-asserted-by":"crossref","DOI":"10.1186\/s40880-018-0325-9","article-title":"Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies","volume":"38","author":"Li","year":"2018","journal-title":"Cancer Commun"},{"key":"2024050214502308900_b45","first-page":"547","article-title":"Segmentation of organs-at-risks in head and neck CT images using convolutional neural networks","author":"Ibragimov","year":"2017"},{"key":"2024050214502308900_b46","volume-title":"Medical Imaging 2018: Biomedical Applications in Molecular, Structural, and Functional Imaging","author":"Tam","year":"2018"},{"key":"2024050214502308900_b47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.radonc.2014.08.028","article-title":"Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer","volume":"112","author":"Walker","year":"2014","journal-title":"Radiotherapy and Oncology"},{"key":"2024050214502308900_b48","doi-asserted-by":"crossref","DOI":"10.1118\/1.4871623","article-title":"Automatic segmentation of head and neck CT images for radiotherapy treatment planning using multiple atlases, statistical appearance models, and geodesic active contours","volume":"41","author":"Fritscher","year":"2014","journal-title":"Med Phys"},{"key":"2024050214502308900_b49","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2017.00315","article-title":"Deep Deconvolutional neural network for Target segmentation of nasopharyngeal cancer in Planning computed Tomography images","volume":"7","author":"Men","year":"2017","journal-title":"Front Oncol"},{"key":"2024050214502308900_b50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiol.2019182012","article-title":"Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma","volume":"291","author":"Lin","year":"2019","journal-title":"Radiology"},{"key":"2024050214502308900_b51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijrobp.2014.11.014","article-title":"Evaluation of a knowledge-based planning solution for head and neck cancer","volume":"91","author":"Tol","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050214502308900_b52","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijrobp.2016.02.017","article-title":"Comparison of planning quality and efficiency between conventional and knowledge-based algorithms in nasopharyngeal cancer patients using intensity modulated radiation therapy","volume":"95","author":"Chang","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050214502308900_b53","first-page":"513","article-title":"Analysis of plasma Epstein\u2013Barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"Int J Cancer"},{"key":"2024050214502308900_b54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(18)30080-9","article-title":"Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study","volume":"19","author":"Tang","year":"2018","journal-title":"Lancet Oncol"},{"key":"2024050214502308900_b55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"2024050214502308900_b56","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ng.3006","article-title":"The genomic landscape of nasopharyngeal carcinoma","volume":"46","author":"Lin","year":"2014","journal-title":"Nat Genet"},{"key":"2024050214502308900_b57","article-title":"Exome and genome sequencing of nasopharynx cancer identifies NF-\u03baB pathway activating mutations","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"2024050214502308900_b58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ijc.29702","article-title":"IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-\u03baB-mediated signalling","volume":"138","author":"Phoon","year":"2016","journal-title":"Int J Cancer"},{"key":"2024050214502308900_b59","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1073\/pnas.1523436113","article-title":"Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma","volume":"113","author":"Dai","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024050214502308900_b60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10070210","article-title":"Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer","volume":"10","author":"Ngan","year":"2018","journal-title":"Cancers"},{"key":"2024050214502308900_b61","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8353","article-title":"Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"key":"2024050214502308900_b62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.4240","article-title":"Identification of a recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma","volume":"231","author":"Chung","year":"2013","journal-title":"J Pathol"},{"key":"2024050214502308900_b63","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4161\/15384047.2014.961874","article-title":"Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma","volume":"15","author":"Yuan","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"2024050214502308900_b64","first-page":"1919","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","author":"Antonia","year":"2017"},{"key":"2024050214502308900_b65","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/COC.0000000000000449","article-title":"Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma","volume":"41","author":"Larbcharoensub","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"2024050214502308900_b66","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1200\/JCO.2017.73.3675","article-title":"Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study","volume":"35","author":"Hsu","year":"2017","journal-title":"J Clin Oncol"},{"key":"2024050214502308900_b67","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.2017.77.0388","article-title":"Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742","volume":"36","author":"Ma","year":"2018","journal-title":"J Clin Oncol"},{"key":"2024050214502308900_b68","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S1470-2045(18)30495-9","article-title":"Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials","volume":"19","author":"Fang","year":"2018","journal-title":"Lancet Oncol"},{"key":"2024050214502308900_b69","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J Exp Med"},{"key":"2024050214502308900_b70","article-title":"Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol"},{"key":"2024050214502308900_b71","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","article-title":"Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas","volume":"86","author":"Zeng","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050214502308900_b72","first-page":"687","article-title":"Irradiation and anti\u2013PD-L1 treatment synergistically promote antitumor immunity in mice","author":"Deng","year":"2014"},{"key":"2024050214502308900_b73","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2024050214502308900_b74","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature24673","article-title":"Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth","volume":"552","author":"Germano","year":"2017","journal-title":"Nature"},{"key":"2024050214502308900_b75","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrclinonc.2016.30","article-title":"Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?","volume":"13","author":"Bernstein","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"2024050214502308900_b76","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/2326-6066.CIR-14-0138","article-title":"PD-1 Restrains Radiotherapy-Induced Abscopal Effect","volume":"3","author":"Park","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2024050214502308900_b77","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jamaoncol.2017.4606","article-title":"Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-edged Sword","volume":"4","author":"Tang","year":"2018","journal-title":"JAMA Oncol"},{"key":"2024050214502308900_b78","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-14-1258","article-title":"Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade","volume":"74","author":"Dovedi","year":"2014","journal-title":"Cancer Res"},{"key":"2024050214502308900_b79","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.4049\/jimmunol.174.12.7516","article-title":"Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor","volume":"174","author":"Lugade","year":"2005","journal-title":"J Immunol"},{"key":"2024050214502308900_b80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/blood-2009-02-206870","article-title":"Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment","volume":"114","author":"Lee","year":"2009","journal-title":"Blood"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/92\/1102\/20190209\/57378332\/bjr.20190209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/92\/1102\/20190209\/57378332\/bjr.20190209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:11:28Z","timestamp":1714662688000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/doi\/10.1259\/bjr.20190209\/7449038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":80,"journal-issue":{"issue":"1102","published-online":{"date-parts":[[2019,7,9]]},"published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1259\/bjr.20190209","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10,1]]},"published":{"date-parts":[[2019,7,9]]},"article-number":"20190209"}}